Filed: 8/14/2023ACC: 0001420506-23-001695
📋 What this filing means
BRAIDWELL LP filed this quarterly 13F‑HR report disclosing 81 equity positions with a total reported market value of $3.06B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
81
Positions
$3.06B
Total AUM (reported)
1.84B
Total Shares
Allocation by class
COM$1.49B48.7%
NOTE 11/1$193.13M6.3%
NOTE 0.375% 3/0$134.69M4.4%
NOTE 11/0$118.18M3.9%
NOTE 2.625% 3/0$115.40M3.8%
NOTE 2.250% 4/0$113.15M3.7%
NOTE 2.500% 3/1$101.09M3.3%
Portfolio Concentration
Top 3$446.00M14.6%
4–10$687.03M22.4%
11–25$796.88M26.0%
Rest$1.13B36.9%
Top 3 weight
14.6%
Top 10 weight
37.0%
Voting Authority Distribution
Total shares with voting rights: 1.84B
Sole
Full voting authority
1.84B
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole81
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings81
Rows:
GUARDANT HEALTH INC
SOLEShares268.25M
TypePRN
Market value$193.13M
6.31%
Sole
268.25M
Shared
0.00
None
0.00
EXACT SCIENCES CORP
SOLEShares131M
TypePRN
Market value$134.69M
4.40%
Sole
131M
Shared
0.00
None
0.00
NOVOCURE LTD
SOLEShares135.83M
TypePRN
Market value$118.18M
3.86%
Sole
135.83M
Shared
0.00
None
0.00
NANOSTRING TECHNOLOGIES INC
SOLEShares145.52M
TypePRN
Market value$115.40M
3.77%
Sole
145.52M
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares124M
TypePRN
Market value$113.15M
3.70%
Sole
124M
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares128.34M
TypePRN
Market value$101.09M
3.30%
Sole
128.34M
Shared
0.00
None
0.00
NEVRO CORP
SOLEShares109.25M
TypePRN
Market value$100.95M
3.30%
Sole
109.25M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares933.36K
TypeSH
Market value$88.02M
2.88%
Sole
933.36K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.72M
TypeSH
Market value$86.01M
2.81%
Sole
1.72M
Shared
0.00
None
0.00
ALPHATEC HLDGS INC
SOLEShares70.75M
TypePRN
Market value$82.41M
2.69%
Sole
70.75M
Shared
0.00
None
0.00
ALIGN TECHNOLOGY INC
SOLEShares224.03K
TypeSH
Market value$79.23M
2.59%
Sole
224.03K
Shared
0.00
None
0.00
GLAUKOS CORP
SOLEShares1.04M
TypeSH
Market value$74.37M
2.43%
Sole
1.04M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares1.83M
TypeSH
Market value$70.39M
2.30%
Sole
1.83M
Shared
0.00
None
0.00
NATERA INC
SOLEShares1.15M
TypeSH
Market value$56.10M
1.83%
Sole
1.15M
Shared
0.00
None
0.00
DECIPHERA PHARMACEUTICALS IN
SOLEShares3.65M
TypeSH
Market value$51.34M
1.68%
Sole
3.65M
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares56.03M
TypePRN
Market value$50.50M
1.65%
Sole
56.03M
Shared
0.00
None
0.00
NUVASIVE INC
SOLEShares55.32M
TypePRN
Market value$50.07M
1.64%
Sole
55.32M
Shared
0.00
None
0.00
IONIS PHARMACEUTICALS INC
SOLEShares52.74M
TypePRN
Market value$50.00M
1.63%
Sole
52.74M
Shared
0.00
None
0.00
IRHYTHM TECHNOLOGIES INC
SOLEShares478.56K
TypeSH
Market value$49.92M
1.63%
Sole
478.56K
Shared
0.00
None
0.00
DICE THERAPEUTICS INC
SOLEShares1.03M
TypeSH
Market value$47.85M
1.56%
Sole
1.03M
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
SOLEShares1.14M
TypeSH
Market value$45.96M
1.50%
Sole
1.14M
Shared
0.00
None
0.00
NEVRO CORP
SOLEShares1.78M
TypeSH
Market value$45.16M
1.48%
Sole
1.78M
Shared
0.00
None
0.00
KARYOPHARM THERAPEUTICS INC
SOLEShares65.98M
TypePRN
Market value$43.02M
1.41%
Sole
65.98M
Shared
0.00
None
0.00
INTUITIVE SURGICAL INC
SOLEShares123.82K
TypeSH
Market value$42.34M
1.38%
Sole
123.82K
Shared
0.00
None
0.00
MERUS N V
SOLEShares1.54M
TypeSH
Market value$40.63M
1.33%
Sole
1.54M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
GUARDANT HEALTH INCSOLE | NOTE 11/1 | 268.25M | PRN | $193.13M 6.31% | 268.25M | 0.00 | 0.00 |
EXACT SCIENCES CORPSOLE | NOTE 0.375% 3/0 | 131M | PRN | $134.69M 4.40% | 131M | 0.00 | 0.00 |
NOVOCURE LTDSOLE | NOTE 11/0 | 135.83M | PRN | $118.18M 3.86% | 135.83M | 0.00 | 0.00 |
NANOSTRING TECHNOLOGIES INCSOLE | NOTE 2.625% 3/0 | 145.52M | PRN | $115.40M 3.77% | 145.52M | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | NOTE 2.250% 4/0 | 124M | PRN | $113.15M 3.70% | 124M | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | NOTE 2.500% 3/1 | 128.34M | PRN | $101.09M 3.30% | 128.34M | 0.00 | 0.00 |
NEVRO CORPSOLE | NOTE 2.750% 4/0 | 109.25M | PRN | $100.95M 3.30% | 109.25M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 933.36K | SH | $88.02M 2.88% | 933.36K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.72M | SH | $86.01M 2.81% | 1.72M | 0.00 | 0.00 |
ALPHATEC HLDGS INCSOLE | NOTE 0.750% 8/0 | 70.75M | PRN | $82.41M 2.69% | 70.75M | 0.00 | 0.00 |
ALIGN TECHNOLOGY INCSOLE | COM | 224.03K | SH | $79.23M 2.59% | 224.03K | 0.00 | 0.00 |
GLAUKOS CORPSOLE | COM | 1.04M | SH | $74.37M 2.43% | 1.04M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 1.83M | SH | $70.39M 2.30% | 1.83M | 0.00 | 0.00 |
NATERA INCSOLE | COM | 1.15M | SH | $56.10M 1.83% | 1.15M | 0.00 | 0.00 |
DECIPHERA PHARMACEUTICALS INSOLE | COM | 3.65M | SH | $51.34M 1.68% | 3.65M | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | NOTE 2.500% 9/1 | 56.03M | PRN | $50.50M 1.65% | 56.03M | 0.00 | 0.00 |
NUVASIVE INCSOLE | NOTE 0.375% 3/1 | 55.32M | PRN | $50.07M 1.64% | 55.32M | 0.00 | 0.00 |
IONIS PHARMACEUTICALS INCSOLE | NOTE 4/0 | 52.74M | PRN | $50.00M 1.63% | 52.74M | 0.00 | 0.00 |
IRHYTHM TECHNOLOGIES INCSOLE | COM | 478.56K | SH | $49.92M 1.63% | 478.56K | 0.00 | 0.00 |
DICE THERAPEUTICS INCSOLE | COM | 1.03M | SH | $47.85M 1.56% | 1.03M | 0.00 | 0.00 |
KEROS THERAPEUTICS INCSOLE | COM | 1.14M | SH | $45.96M 1.50% | 1.14M | 0.00 | 0.00 |
NEVRO CORPSOLE | COM | 1.78M | SH | $45.16M 1.48% | 1.78M | 0.00 | 0.00 |
KARYOPHARM THERAPEUTICS INCSOLE | NOTE 3.000%10/1 | 65.98M | PRN | $43.02M 1.41% | 65.98M | 0.00 | 0.00 |
INTUITIVE SURGICAL INCSOLE | COM NEW | 123.82K | SH | $42.34M 1.38% | 123.82K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 1.54M | SH | $40.63M 1.33% | 1.54M | 0.00 | 0.00 |
Page 1 of 4